- Health & Pharmaceuticals›
- Pharmaceutical Products & Market›
Global spending on medicines 2010-2023
Premium statistics
Industry-specific and extensively researched technical data (partially from exclusive partnerships).
A paid subscription is required for full access.
Global spending on medicines 2010-2023
Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)
by Matej Mikulic,
last edited
Aug 27, 2019
Global spending on medicine continues to grow. As of 2018, approximately 1.2 trillion U.S. dollars had been spent on medicines, up from just 887 billion U.S. dollars in 2010. That number is expected to increase to 1.52 by the year 2023. Spending on medicines has increased everywhere globally. However, the United States takes the lead in total medicines spending globally and is expected to remain the top country for medicines spending through 2023.
Global pharmaceutical industry
Globally the pharmaceutical industry is a growing industry fueled by aging populations and new drugs to treat rare and specialty diseases. Regionally, the pharmaceutical industry generates the most revenue through the North American and European markets. Within all markets globally the top therapeutic class is oncology, followed by antidiabetics.Top pharmaceutical companies
There are several large pharma companies that participate in the global pharmaceutical industry. As of 2018, U.S.-based pharmaceutical company Johnson & Johnson was the top pharmaceutical company, followed by Pfizer, based on market capitalization. Among pharmaceutical companies, some have produced more new drugs than others. The U.S. and Europe are responsible for the largest number of new pharmaceutical substances from 2013 to 2017.Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)
| Spending in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
| Spending in billion U.S. dollars | |
|---|---|
| - | - |
| - | - |
| - | - |
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
Exclusive content
Exclusive Premium statistic
You need a Premium Account for unlimited access.
Full access to 1m statistics
Incl. source references
Available to download in PNG, PDF, XLS format
Premium Account
only $49 / month
*
© Statista 2019
About this statistic
Show source
Download
Settings
Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Please be patient - this may take a moment
Description
Source
More information
by Matej Mikulic,
last edited
Aug 27, 2019
Global spending on medicine continues to grow. As of 2018, approximately 1.2 trillion U.S. dollars had been spent on medicines, up from just 887 billion U.S. dollars in 2010. That number is expected to increase to 1.52 by the year 2023. Spending on medicines has increased everywhere globally. However, the United States takes the lead in total medicines spending globally and is expected to remain the top country for medicines spending through 2023.
Global pharmaceutical industry
Globally the pharmaceutical industry is a growing industry fueled by aging populations and new drugs to treat rare and specialty diseases. Regionally, the pharmaceutical industry generates the most revenue through the North American and European markets. Within all markets globally the top therapeutic class is oncology, followed by antidiabetics.Top pharmaceutical companies
There are several large pharma companies that participate in the global pharmaceutical industry. As of 2018, U.S.-based pharmaceutical company Johnson & Johnson was the top pharmaceutical company, followed by Pfizer, based on market capitalization. Among pharmaceutical companies, some have produced more new drugs than others. The U.S. and Europe are responsible for the largest number of new pharmaceutical substances from 2013 to 2017.- Show sources information
- Show publisher information
- Release date
- January 2019
- Region
- Worldwide
- Survey time period
- as of December 2018
- Supplementary notes
-
* Value for 2023 is an average of the high and low forecast values (1,505 bn and 1,535 bn).
Figures for 2010 were taken from a previous report by the same source. - Open this statistic in...
Source
- Show sources information
- Show publisher information
- Release date
- January 2019
More information
- Region
- Worldwide
- Survey time period
- as of December 2018
- Supplementary notes
-
* Value for 2023 is an average of the high and low forecast values (1,505 bn and 1,535 bn).
Figures for 2010 were taken from a previous report by the same source. - Open this statistic in...
Other statistics on the topic
Global Pharmaceutical Industry
+Pharmaceutical Products & Market
2018 list of global top 10 biotech and pharmaceutical companies based on net income
+Pharmaceutical Products & Market
Total global pharmaceutical R&D spending 2010-2024
+Pharmaceutical Products & Market
World pharmaceutical sales 2016-2018 by region
+Pharmaceutical Products & Market
Top therapeutic classes by global pharmaceutical sales 2018 estimates
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account!
Premium Account
Your perfect start with Statista
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$49 / Month *
Corporate Account
Full access
Corporate solution including all features.
* All products require an annual contract.
Prices do not include sales tax.
Prices do not include sales tax.
Leading companies trust Statista:
Related Studies: Available to Download in PDF or PPTX Format
All Information
in one Presentation
Global pharmaceutical industry
- 81 page/s
- English
- pptx
- Detailed references
Everything On "Global pharmaceutical industry" in One Document: Edited and Divided into Handy Chapters. Including Detailed References.
Other Reports & Dossiers
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Statistics on "Global pharmaceutical industry"
- Overview
The most important statistics
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)Pharmaceutical market: worldwide revenue 2001-2018
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by regionGlobal pharmaceutical market - revenue distribution 2010-2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*World pharmaceutical sales 2016-2018 by region
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*World pharmaceutical market distribution by submarket 2014-2018
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*Top 10 global pharmaceutical markets: growth 2012-2017
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)Top therapeutic classes by global pharmaceutical sales 2018 estimates
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*Spending growth of top pharmaceutical therapeutic classes by CAGR 2014-2018
- Companies and products
The most important statistics
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)Top 50 pharmaceutical companies - Rx sales and R&D spending 2018
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)2018 list of global top 10 biotech and pharmaceutical companies based on net income
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)Top 10 biotech and pharmaceutical companies based on market cap 2019
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018Top pharmaceutical companies by capex growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)Top pharmaceutical products by sales worldwide 2018
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*Revenues of leading global generics manufacturers 2018
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)Top cancer drugs based on revenue worldwide 2018
- Top companies by revenue
The most important statistics
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)Pfizer's total revenue 2006-2018
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*Pfizer's revenue by segment 2014-2018
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)Novartis' revenue 2007-2018
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)Novartis revenue 2014-2018 by segment
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)Roche Group's total sales 2006-2018
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)Roche Group's total sales by division 2013-2018
- R&D, patents, new products
The most important statistics
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)Total global pharmaceutical R&D spending 2010-2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*Patent expiration risks for total worldwide prescription drug revenue 2010-2024
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024Worldwide prescription drug revenue - market risk from patent expiration 2010-2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)Projected sales at risk due to patent expiry 2009-2022
- Number of new chemical or biological entities developed between 1992 and 2018, by region of originPharmaceutical industry - number of new substances 1992-2018
- Total number of novel drugs approved by CDER from 2008 to 2018Number of novel drugs approved annually by CDER 2008-2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)Projection of top 2018 pharma and biotech launches by revenue 2022
- Outlook
The most important statistics
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*World pharmaceutical sales by region forecast 2022
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by countryPharmaceutical sector growth worldwide 2017-2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)Global spending on medicines 2010-2023
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)Country comparison in spending on medicine 2023
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)Leading global pharmaceutical products and respective revenues 2024
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)Global top pharmaceutical companies based on R&D spending 2024
Discover Statista
Need help with using Statista for your research?
Tutorials and first steps
Further Content: Statistics, Studies, and Topic Pages
Statistics
- Pharmaceutical expenditure forecast worldwide by country 2030
- Annual change in pharmaceutical cost in Sweden 2007-2017
- Spending on pharmaceuticals in the United Kingdom (UK) 2003-2014
- Health expenditure on pharmaceuticals and medical non-durables in Belgium 2003-2013
- Health expenditure on pharmaceuticals and medical non-durables in Slovenia 2005-2015
- Italy: pharmaceutical expenditure as share of healthcare spending 2007-2017
- Health expenditure on pharmaceuticals and medical non-durables in Germany 2005-2015
- Health expenditure on pharmaceuticals and medical non-durables in Cyprus 2005-2015
- Health expenditure on pharmaceuticals and medical non-durables in Portugal 2005-2015
- Health expenditure on pharmaceuticals and medical non-durables in Bulgaria 2005-2015
- Health expenditure on pharmaceuticals and medical non-durables in Poland 2003-2013
- Health expenditure on pharmaceuticals and medical non-durables in Malta 2005-2014
- Health expenditure on pharmaceuticals and medical non-durables in Luxembourg 2005-15
- Health expenditure on pharmaceuticals and medical non-durables in France 2003-2013
- Italy: leading active ingredients 2016, by level of public spending
- Import value of medical instruments from Saudi Arabia to North Africa 2011-2015
- Health expenditure on pharmaceuticals and medical non-durables in Romania 2005-2015
- Import value of pharmaceuticals in North Africa 2011-2015
- Value of imports of pharmaceutical products from Hungary to Spain 2012-2016
- GDP expenditure on prevention and public health services in Germany 2005-2015
Studies
- Pharmaceutical market in Italy
- Pharmaceutical market in Sweden
- Pharmaceutical market in Norway
- Pharmaceutical industry in the United Kingdom (UK)
- Pharmaceutical industry in Denmark
- Pharmaceutical industry in Sweden
- Pharmaceutical industry in Norway
- Pharmaceutical trends in Europe
- Global pharmaceutical industry
- Orphan drugs
- Canadian pharmaceutical industry
- Pharmaceutical industry in Mexico
- Medicines Use and Spending in the U.S. - A Review of 2018 and Outlook to 2023
- Prescribed Drug Spending in Canada, 2018
- EvaluatePharma - World Preview 2019, Outlook to 2024
Statistics on "Global pharmaceutical industry"
- Revenue of the worldwide pharmaceutical market from 2001 to 2018 (in billion U.S. dollars)
- Distribution of global pharmaceutical market revenue from 2010 to 2018, by region
- Global pharmaceutical sales from 2016 to 2018, by region (in billion U.S. dollars)*
- Distribution of the total global pharmaceutical market sales from 2014 to 2018, by submarket*
- Growth of top 10 national pharmaceutical markets worldwide from 2012 to 2017*
- Top 10 therapeutic classes by estimated global pharmaceutical sales in 2018 (in billion U.S. dollars)
- Global spending growth in selected pharmaceutical major therapeutic classes between 2014 and 2018*
- Top 50 global pharmaceutical companies by prescription sales and R&D spending in 2018 (in billion U.S. dollars)
- 2018 ranking of the global top 10 biotech and pharmaceutical companies based on net income (in billion U.S. dollars)
- Top 10 biotech and pharmaceutical companies worldwide based on market capitalization as of 2019 (in billion U.S. dollars)
- World's top 50 pharmaceutical and biotechnology companies based on capital expenditure growth in 2017/2018
- Top 15 pharmaceutical products by sales worldwide in 2018 (in million U.S. dollars)
- Top generics manufacturers based on revenue in 2018 (in billion U.S. dollars)*
- Top 10 cancer drugs worldwide by revenue in 2018 (in billion U.S. dollars)
- Pfizer's total revenue from 2006 to 2018 (in million U.S. dollars)
- Pfizer's revenue in 2014 and 2018, by segment (in million U.S. dollars)*
- Novartis AG's total revenue from 2007 to 2018 (in billion U.S. dollars)
- Novartis AG's revenue from 2014 to 2018, by segment (in billion U.S. dollars)
- Total sales of the Roche Group from 2006 to 2018 (in million Swiss francs)
- Total sales of the Roche Group from 2013 to 2018, by division (in million Swiss francs)
- Total global spending on pharmaceutical research and development from 2010 to 2024 (in billion U.S. dollars)
- Global top 10 pharmaceutical companies based on projected R&D spending in 2024 (in billion U.S. dollars)
- Worldwide total prescription drug revenue at risk from patent expiration from 2010 to 2024 (in billion U.S. dollars)*
- Percentage of global prescription drug revenue at risk from patent expiration from 2010 to 2024
- Small molecules sales at risk due to patent expirations in the U.S. from 2009 to 2022 (in billion U.S. dollars)
- Number of new chemical or biological entities developed between 1992 and 2018, by region of origin
- Total number of novel drugs approved by CDER from 2008 to 2018
- Top biotech and pharma product launches in 2018 and revenue forecast for 2022 (in million U.S. dollars)
- Selected top pharmaceutical R&D projects based on net present value (NPV) as of May 2019 (in million U.S. dollars)
- Projected global pharmaceutical sales for 2022, by region (in billion U.S. dollars)*
- Worldwide forecast of pharmaceutical sector growth between 2017 and 2030, by country
- Global spending on medicines in 2010, 2018, and a forecast for 2023 (in billion U.S. dollars)
- Projected expenditure on medicine of selected countries worldwide in 2023 (in billion U.S. dollars)
- Projected top 10 global pharmaceutical products by revenue in 2024 (in million U.S. dollars)
- Worldwide forecast of pharmaceutical expenditures in 2030, by country (in million U.S. dollars)*
- Annual change in pharmaceutical cost in Sweden from 2007 to 2017
- Annual spending on pharmaceuticals in the United Kingdom (UK) between 2003 and 2014 (in U.S. dollars per capita)
- Share of health expenditure on pharmaceuticals and other medical non-durables in Belgium from 2003 to 2013
- Share of current health expenditure on pharmaceuticals and other medical non-durables in Slovenia from 2005 to 2015
- Share of public health expenditure on pharmaceuticals in Italy from 2007 to 2017
- Share of current health expenditure on pharmaceuticals and other medical non-durables in Germany from 2005 to 2015
- Share of current health expenditure on pharmaceuticals and other medical non-durables in Cyprus from 2005 to 2015
- Share of current health expenditure on pharmaceuticals and other medical non-durables in Portugal from 2005 to 2015
- Share of current health expenditure on pharmaceuticals and other medical non-durables in Bulgaria from 2005 to 2015
- Share of current health expenditure on pharmaceuticals and other medical non-durables in Poland from 2003 to 2013
- Share of current health expenditure on pharmaceuticals and other medical non-durables in Malta from 2005 to 2014
- Share of current health expenditure on pharmaceuticals and other medical non-durables in Luxembourg from 2005 to 2015
- Share of current health expenditure on pharmaceuticals and other medical non-durables in France from 2003 to 2013
- Leading off patent active ingredients in Italy as of 2016, by level of public spending (in million euros)
- Value of medical instruments imports from Saudi Arabia to North Africa from 2011 to 2015 (in million Saudi Arabian Riyal)
- Share of current health expenditure on pharmaceuticals and other medical non-durables in Romania from 2005 to 2015
- Value of pharmaceutical imports in North Africa from 2011 to 2015 (in billion Saudi Arabian Riyal)
- Value of total imports of pharmaceutical products from Hungary to Spain from 2012 to 2016 (in 1,000s U.S. dollars)
- Share of GDP expenditure on prevention and public health services in Germany from 2005 to 2015
Statista Accounts:
Access All Statistics. Starting from $588 / Year
Related topics
About Statista
Statista offers dossiers and reports on over 170 industries. With Statista you are always able to make informed decisions and boost your work efficiency.
Internet & Telecommunications
- Social Media
- E-Commerce
- Online Video & Entertainment
- Advertising & Marketing
Consumer Goods & FMCG
- Alcoholic Beverages
- Cleaning Products
- Cosmetics & Personal Care
- Food & Nutrition
Retail & Trade
- Health & Hygiene
- International Trade
- Shopping Behavior
- Sports & Leisure
Travel, Tourism & Hospitality
- Business Travel
- Leisure Travel
- Accomodation
- Restaurants
Society
- Demographics
- Economy
- Education & Science
- Politics & Government
Transportation & Logistics
- Aviation
- Rail Transport
- Vehicles & Road Traffic
- Water Transport
Save statistic in .XLS format
You can only download this statistic as a Premium user.
Save statistic in .PNG format
You can only download this statistic as a Premium user.
Save statistic in .PDF format
You can only download this statistic as a Premium user.
Show source references
As a Premium user you get access to the detailed source references and background information about this statistic.
Show details about this statistic
As a Premium user you get access to background information and details about the release of this statistic.
Bookmark statistics
As soon as this statistic is updated, you will immediately be notified via e-mail.
Change statistics options
You need at least a Premium Account to use this feature.
Exclusive Corporate feature
This feature is limited to our corporate solutions.
Please contact us to get started with full access to dossiers, forecasts, studies and international data.
Corporate Account
We use cookies to personalize contents and ads, offer social media features, and analyze access to our website. In your browser settings you can configure or disable this, respectively, and can delete any already placed cookies. For details, please see your browser’s Help section (by pressing F1). Please see our privacy statement for details about how we use data.